Why Is Cerebras Systems (CBRS) Stock Down -11% Today?
Key Takeaways
- CBRS shares are down approximately 11% in premarket trading on Wednesday, June 24, 2026, following an after-hours selloff triggered by the company's first earnings report as a public company.
- Cerebras beat Q1 revenue expectations with $193.4 million — a 92% year-over-year surge — but missed on earnings per share and issued a gross margin forecast that unsettled investors.
- The company guided Q2 2026 core gross margins of 36%–38%, a sharp drop from the 47% reported in Q1, raising concerns about the company's ability to compete with AI chip rivals.
- Full-year 2026 adjusted gross margin guidance of 38%–41% trails significantly behind Nvidia (mid-70s) and AMD (mid-50s), drawing scrutiny from market participants.
- The broader context includes elevated investor expectations following Cerebras' blockbuster May 2026 IPO, which raised $5.5 billion and priced in aggressive growth assumptions.
- Traders will watch for analyst commentary and any management clarifications on the margin compression trajectory in the coming sessions.
Opening Summary
Cerebras Systems Inc. (CBRS) is a Silicon Valley-based AI infrastructure company that designs and manufactures high-performance AI chips — including the Wafer Scale Engine — optimized for inference workloads. The company went public in May 2026 in one of the largest IPOs of the year, raising $5.5 billion amid intense investor enthusiasm for AI semiconductor plays.
CBRS shares closed Tuesday's regular session at $226.72, then plunged in after-hours trading and extended those losses into Wednesday's premarket, with the stock quoted near $201.50 — a decline of approximately $25.22, or 11.12%, from the prior close. The immediate trigger was the company's first quarterly earnings report as a public company, which delivered a mixed set of results: revenue that beat expectations but an EPS miss and, critically, a forward gross margin outlook that fell well short of investor hopes.
Earnings Miss and Margin Warning
Cerebras reported Q1 2026 core revenue of $191.3 million — a 92% year-over-year increase — and total GAAP revenue of $193.4 million, which beat the FactSet analyst consensus of $181.2 million. Hardware revenue grew 59% year-over-year to $110.6 million, while cloud and services revenue surged 178% to $82.8 million, reflecting the company's ongoing pivot toward recurring cloud-based revenue.
However, the bottom line disappointed. Cerebras posted a GAAP net loss of $14.0 million, and while the non-GAAP loss of $2.5 million significantly beat analyst expectations of a $36.75 million adjusted loss, the EPS figure came in at a loss of $0.22 per share versus the consensus estimate of a $0.16 loss. The earnings shortfall, combined with forward guidance, proved to be the decisive catalyst for the selloff.
Gross Margin Compression Takes Center Stage
The most damaging element of Tuesday's report was the margin guidance. For Q2 2026, Cerebras forecast core gross margins of only 36%–38%, representing a significant step-down from the 47% core gross margin delivered in Q1. For full-year 2026, the company guided to adjusted gross margins of 38%–41%.
While those figures exceeded the analyst consensus of 29.58%, investors immediately framed the numbers against the competitive landscape. Nvidia's gross margins sit in the mid-70% range; AMD's are in the mid-50s. The gap underscores a structural challenge for Cerebras: it competes at the high end of AI inference hardware yet generates substantially thinner margins than its established rivals. The acknowledgment of near-term margin compression — even alongside strong top-line growth — was sufficient to push CBRS sharply lower.
Revenue Guidance and OpenAI Partnership
Not everything in the report was negative. Cerebras issued full-year 2026 adjusted revenue guidance of $855 million to $865 million, representing approximately 69% growth at the midpoint and surpassing the Street's estimate of $823.9 million. The company also announced a landmark multi-year deal with OpenAI for 750 megawatts of deployed Cerebras chips, a contract valued at more than $20 billion. For Q2 2026, revenue guidance of $194 million also came in above consensus.
Despite this, markets chose to focus on margin deterioration as the more pressing near-term concern. The revenue beat and landmark deal provided limited upside support against the weight of the gross margin outlook.
Market Context and Trading Activity
The after-hours and premarket selloff unfolded in isolation from the broader tape — major indices did not experience comparable moves. The reaction was stock-specific and earnings-driven. Trading volume on Tuesday's regular session was elevated at approximately 6.78 million shares, already reflecting anticipation ahead of the earnings release. The inverse leveraged ETF CBRZ — the Tradr 2X Short CBRS Daily ETF — surged more than 26% in premarket trading, confirming the directional severity of the move in CBRS.
It is worth noting that CBRS has already declined roughly 28% from its post-IPO peak, meaning Wednesday's move extends a correction that began shortly after the May 2026 debut. Support levels from the post-IPO consolidation range are now in focus as traders assess the stock's next floor.
Trending AI Robots
For traders and investors navigating volatile AI stocks like CBRS, Tickeron offers an extensive suite of AI-powered trading tools. With hundreds of bots covering thousands of tickers, Tickeron's platform spans a wide range of strategies, timeframes, and risk profiles. Not all bots perform equally under every market condition — which is why Tickeron curates a dedicated Trending AI Robots page, showcasing only the strongest-performing bots given the current market environment. Each featured bot is evaluated on performance metrics, traded symbols, and strategy type. Whether you're focused on momentum plays, mean reversion, or sector rotation, the Trending AI Robots section offers a data-driven starting point for exploring automated trading strategies suited to today's conditions.
What Comes Next for CBRS
The immediate focus will be on analyst reactions in the days following Tuesday's earnings report. Multiple sell-side desks are expected to revisit price targets and models to reflect the revised margin trajectory. Management's ability to articulate a credible path back to expanding margins — whether through scale efficiencies, customer mix shifts, or chip architecture improvements — will be critical to rebuilding investor confidence.
On the fundamental side, the evolution of the OpenAI partnership and whether Cerebras can diversify its customer base beyond a concentrated handful of hyperscale clients will be closely monitored. The company has cited capacity constraints in its forward guidance, suggesting supply-side factors are also capping near-term margin improvement.
Macro conditions for AI semiconductor stocks remain in flux, with investor sentiment sensitive to both Federal Reserve policy developments and broader capital expenditure trends among hyperscalers. The Q2 2026 earnings cycle, expected later this year, will be the next major opportunity for CBRS to demonstrate whether the margin compression is transitory or structural.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
CBRS's RSI Oscillator entering oversold zone
The RSI Indicator for CBRS moved into overbought territory on October 12, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CBRS as a result. In 8 of 8 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CBRS turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 1 similar instances when the indicator turned negative. In 1 of the 1 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CBRS moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBRS entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 70 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.105) is normal, around the industry mean (7.975). CBRS has a moderately high P/E Ratio (470.757) as compared to the industry average of (165.532). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.761). Dividend Yield (0.000) settles around the average of (0.007) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (45.794).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry Semiconductors
Advertisement